Vasavi Vittal joined ICM in 2021 as a Senior Analyst based in Singapore. Vasavi has been involved in investment analysis and management, corporate finance, and strategy for the last sixteen years. Prior to that, she was a research scientist in biotech and biochemistry and has co-authored several published scientific papers. Vasavi is focused on the healthcare and med-tech sectors at Allectus. She has an MBA with a focus on Finance from Said Business School at the University of Oxford, as well as a MS in Biochemistry from University of Maryland.